前沿生物-U
(688221)
| 流通市值：11.96亿 | | | 总市值：20.86亿 |
| 流通股本：2.15亿 | | | 总股本：3.75亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 526,663,249.91 | 726,501,291.79 | 498,337,237.99 | 592,178,637.6 |
| 应收票据及应收账款 | 63,008,781.14 | 54,523,968.59 | 43,287,359.36 | 37,176,717.03 |
| 应收账款 | 63,008,781.14 | 54,523,968.59 | 43,287,359.36 | 37,176,717.03 |
| 预付款项 | 23,479,570.17 | 39,392,317.94 | 41,245,025.32 | 51,452,703.17 |
| 其他应收款合计 | 2,370,670.36 | 3,726,023.77 | 3,625,848.12 | 4,769,405.38 |
| 存货 | 59,002,295.21 | 51,109,453.83 | 54,069,111.93 | 71,503,812.77 |
| 其他流动资产 | 13,203,675.84 | 9,767,495.2 | 12,651,084.56 | 8,830,766.4 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,102,785,645.43 | 1,174,040,848.69 | 1,230,045,849.28 | 1,306,644,541.44 |
| 非流动资产: | | | | |
| 固定资产 | 94,079,786.32 | 96,398,187.68 | 98,377,547.32 | 99,742,066.39 |
| 在建工程 | 695,969,059.79 | 675,501,736.34 | 657,376,356.58 | 649,659,858.88 |
| 使用权资产 | 2,969,157.24 | 3,783,364.17 | 4,412,058.3 | 3,060,601.43 |
| 无形资产 | 229,175,249.41 | 238,666,559.66 | 246,895,792.05 | 256,427,840.14 |
| 长期待摊费用 | 935,702.1 | 1,336,095.54 | 1,551,038.81 | 2,052,106.38 |
| 其他非流动资产 | 14,211,895.95 | 11,753,196.48 | 15,481,768.51 | 16,260,046.35 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,037,340,850.81 | 1,027,439,139.87 | 1,024,094,561.57 | 1,027,202,519.57 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,140,126,496.24 | 2,201,479,988.56 | 2,254,140,410.85 | 2,333,847,061.01 |
| 流动负债: | | | | |
| 短期借款 | 202,299,231.94 | 218,891,605.71 | 224,356,010.65 | 175,160,439.53 |
| 应付票据及应付账款 | 17,435,238.06 | 25,937,856.89 | 9,718,563.96 | 39,870,682.99 |
| 应付账款 | 17,435,238.06 | 25,937,856.89 | 9,718,563.96 | 39,870,682.99 |
| 预收款项 | - | - | 9,174.31 | 300 |
| 合同负债 | 5,832,452.69 | 671,614.92 | 280,027.58 | 263,853.89 |
| 应付职工薪酬 | 19,634,852.68 | 13,563,599.53 | 12,834,989.88 | 11,950,157.29 |
| 应交税费 | 634,758.7 | 810,797.82 | 445,539.1 | 875,427.29 |
| 其他应付款合计 | 23,052,308.95 | 33,568,435.59 | 25,666,278.58 | 27,320,638.41 |
| 其中:应付利息 | 986,240.01 | 399,976.27 | 398,611.45 | 368,533.04 |
| 一年内到期的非流动负债 | 111,187,494.66 | 22,804,423.98 | 22,046,407.23 | 12,472,629.65 |
| 其他流动负债 | 81,834.18 | 75,576 | 17,679.33 | 16,772.61 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 380,158,171.86 | 316,323,910.44 | 295,374,670.62 | 267,930,901.66 |
| 非流动负债: | | | | |
| 长期借款 | 71,420,000 | 112,195,800 | 114,115,105 | 124,365,105 |
| 租赁负债 | 169,537.84 | 337,019.17 | 1,402,810.82 | 450,338.73 |
| 长期应付款 | 230,981,661.68 | 226,436,370.24 | 226,189,994.3 | 224,946,402.03 |
| 递延收益 | 114,715,037.41 | 117,006,191.46 | 118,501,076.85 | 120,235,320.45 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 417,286,236.93 | 455,975,380.87 | 460,208,986.97 | 469,997,166.21 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 797,444,408.79 | 772,299,291.31 | 755,583,657.59 | 737,928,067.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 374,578,653 | 374,578,653 | 374,578,653 | 374,578,653 |
| 资本公积 | 2,723,191,887.05 | 2,723,185,564.15 | 2,723,176,079.8 | 2,723,166,595.45 |
| 其他综合收益 | 10,839.09 | 17,770.8 | 21,414.05 | 17,002.3 |
| 未分配利润 | -1,755,099,291.69 | -1,668,601,290.7 | -1,599,219,393.59 | -1,501,843,257.61 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,342,682,087.45 | 1,429,180,697.25 | 1,498,556,753.26 | 1,595,918,993.14 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,342,682,087.45 | 1,429,180,697.25 | 1,498,556,753.26 | 1,595,918,993.14 |
| 负债和股东权益合计 | 2,140,126,496.24 | 2,201,479,988.56 | 2,254,140,410.85 | 2,333,847,061.01 |
| 公告日期 | 2024-03-30 | 2023-10-31 | 2023-08-30 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |